INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

APUSApimeds Pharmaceuticals US, Inc.

CIK 0001894525

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections4with evidence

APUS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KJ
Koo JakapDirector
APUSApimeds Pharmaceuticals US, Inc.
Grant or award
A—
10.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 5, 2026
  • ← Insider ofevidence
    Koo JakapDirector · Nov 13, 2025
  • ← Insider ofevidence
    Yoon HankilDirector · Nov 13, 2025
  • ← Insider ofevidence
    Weintraub BennettDirector · Nov 13, 2025
9
YH
Yoon HankilDirector
APUSApimeds Pharmaceuticals US, Inc.
Grant or award
A
—
10.0K sh
Nov 11, 2025
Nov 13, 2025
traded Nov 11, 2025
+2d
SEC FORM 4

Evidence

9
WB
Weintraub BennettDirector
APUSApimeds Pharmaceuticals US, Inc.
Grant or award
A—
10.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC FORM 4

Evidence